Glaxo gets ready for next pandemic after Covid vaccine production stumbles in UK
Glaxo’s main R&D vaccine hubs currently are based in Belgium, Italy and the US, with manufacturing capacity globally, including the UK
Glaxo’s main R&D vaccine hubs currently are based in Belgium, Italy and the US, with manufacturing capacity globally, including the UK
0 Comments
Post a Comment